Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 52Unknown 20Recruiting 20Terminated 19Active not recruiting 5Withdrawn 4Not yet recruiting 4Enrolling by invitation 3Suspended 2

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 1CNS 1

Conditions

Prostatic Neoplasms 1Meningioma 1

Interventions

Specimen Handling 29Magnetic Resonance Spectroscopy 18Biopsy 16Cyclophosphamide 15Nivolumab 10Paclitaxel 9Vincristine 8Cisplatin 8venetoclax 7Prednisone 7Gemcitabine 7Doxorubicin 7Bevacizumab 7Azacitidine 7pembrolizumab 6Radiotherapy 6Fluorouracil 6Etoposide 6Drug Therapy 6Docetaxel 6Rituximab 5Radiosurgery 5Oxaliplatin 5Irinotecan 5Injections 5Everolimus 5Capecitabine 5fludarabine phosphate 4Taxes 4Surgical Procedures, Operative 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Interventional × Magnetic Resonance Imaging × Clear all
NCT07353229 2026-01-23

68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High Risk Meningioma

Thomas Jefferson University

Phase 1 Suspended
24 enrolled
CNS

Meningioma

NCT06185478 2023-12-29

Prostate Diffusion Imaging With Distortion Correction

Norfolk and Norwich University Hospitals NHS Foundation Trust

Phase NA Suspended
70 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡